Management of Locoregional Recurrence in Breast Cancer

Article
Conference|San Antonio Breast Cancer Symposium (SABCS)

This video highlights an education session from SABCS on the management of locoregional recurrence in breast cancer.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, William J. Gradishar, MD, of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, reviews the management of locoregional recurrence in breast cancer.

      Gradishar took part in a session on this topic at the 2017 San Antonio Breast Cancer Symposium (SABCS), held December 5–9 in San Antonio, Texas.

      Recent Videos
      Prior studies, like the phase 3 VISION trial, may support the notion of combining radiopharmaceuticals with best supportive care.
      ProstACT GLOBAL Results May Support “Open” Decisions in Metastatic CRPC
      Beta emitters like 177Lu-rosopatamab may offer built-in PSMA imaging during the treatment of patients with metastatic castration-resistant prostate cancer.
      Leveraging Beta and Alpha Emitters in Metastatic CRPC Management
      TAR-200 Might Be “Best in Class” for BCG-Unresponsive High-Risk NMIBC
      TAR-200 Might Be “Best in Class” for BCG-Unresponsive High-Risk NMIBC
      Ongoing ctDNA analysis may elucidate outcomes associated with divarasib plus migoprotafib for those with KRAS G12C–positive NSCLC.
      Divarasib Combo Appears “Promising” in Pretreated KRAS G12C+ NSCLC
      Clinical trials conducted in recent years demonstrate the benefit of integrative oncology for patients undergoing treatment for cancer.
      Outlining Strategies for Effectively Implementing Integrative Oncology Care
      Navigating the Difficulties of Nutrition During Cancer Care as a Nurse
      Navigating the Difficulties of Nutrition During Cancer Care as a Nurse
      Genetic Counseling Referrals Rely on Genetic Report Examinations
      Genetic Counseling Referrals Rely on Genetic Report Examinations
      Spatial transcriptomics and multiplex immunohistochemistry from samples may elucidate outcomes for patients who undergo surgical care for cancer.
      Molecular Diagnostics, PIPAC Appear "Exciting" in GI Cancer Surgical Care
      Future work may focus on optimizing symptom management associated with percutaneous transesophageal gastrostomy placement in malignant bowel obstructions.
      Prospective Study May Clarify PTEG Benefits in Malignant Bowel Obstruction
      Post-operative length of stay ranged from 4 to 9 days for patients who underwent percutaneous transesophageal gastrostomy for malignant bowel obstructions.
      PTEG Elicits Encouraging Technical Outcomes in Malignant Bowel Obstruction
      Related Content
      65 The Outcomes of Nipple Sparing Goldilocks Mastectomy in a Primarily Overweight and Obese Population

      65 The Outcomes of Nipple Sparing Goldilocks Mastectomy in a Primarily Overweight and Obese Population

      Allen Gee;Grace Oh;June Lee
      May 12th 2025
      Article
      Key CAR T and Transplantation Presentations From The 2025 Tandem Meeting

      Key CAR T and Transplantation Presentations From The 2025 Tandem Meeting

      Rahul Banerjee, MD, FACP;Shernan Holtan, MD
      March 3rd 2025
      Podcast

      Shernan Holtan, MD, and Rahul Banerjee, MD, FACP, discussed various trials of significance shared as posters and presentations at the 2025 Tandem Meeting.

      68 Upper Extremity Disability Assessment Following Breast Cancer Surgery Using QuickDASH in an Ethnic Minority Population

      68 Upper Extremity Disability Assessment Following Breast Cancer Surgery Using QuickDASH in an Ethnic Minority Population

      Arianna Cavalli;Susan Laura Jao;Skylar Harbour;Melissa Rony;Sheldon Feldman;Maureen McEvoy
      May 10th 2025
      Article
      Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.

      SABCS 2024 Data Show ‘Great Steps Forward’ in Breast Cancer Care

      Paolo Tarantino, MD;Matteo Lambertini, MD
      January 13th 2025
      Podcast

      Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.

      70 Malignancy Upgrade Rates of Discordant Breast Lesions

      70 Malignancy Upgrade Rates of Discordant Breast Lesions

      Jacquelyn Dillon;Carolyn Vanek;Jeanne Wu;Grace Van Hyfte;Victoria Collins;Christine Chen;Elisa Port;Jennifer L. Marti
      May 9th 2025
      Article
      71 Beyond the Surface: Suspicious Nipple Lesions

      71 Beyond the Surface: Suspicious Nipple Lesions

      Margarita Riojas Barrett;Logan Healy;Neil Farnsworth;Elizabeth Bonefas;Alastair Thompson;Stacey Carter
      May 8th 2025
      Article